Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 91.06B | 85.90B | 77.71B | 72.70B | 66.91B |
Gross Profit | 20.13B | 19.41B | 17.38B | 16.85B | 16.01B |
EBITDA | 2.57B | 2.94B | 1.77B | 2.32B | 2.13B |
Net Income | 1.05B | 1.34B | 358.19M | 798.55M | 858.21M |
Balance Sheet | |||||
Total Assets | 24.08B | 23.65B | 22.02B | 21.38B | 19.22B |
Cash, Cash Equivalents and Short-Term Investments | 4.78B | 4.90B | 3.51B | 3.62B | 2.62B |
Total Debt | 3.34B | 3.73B | 4.81B | 4.43B | 3.45B |
Total Liabilities | 12.88B | 13.29B | 12.94B | 12.53B | 11.08B |
Stockholders Equity | 11.20B | 10.36B | 9.07B | 8.85B | 8.13B |
Cash Flow | |||||
Free Cash Flow | 1.34B | 2.75B | 162.40M | 541.16M | 702.61M |
Operating Cash Flow | 1.90B | 3.46B | 1.28B | 1.56B | 1.66B |
Investing Cash Flow | -810.80M | -698.79M | -1.34B | -1.07B | -997.13M |
Financing Cash Flow | -1.21B | -1.37B | -47.35M | 526.74M | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.94B | 7.41 | 2.28% | 15.66% | 2.88% | ||
76 Outperform | ¥12.42B | 11.81 | 1.07% | 6.01% | -21.51% | ||
75 Outperform | ¥8.85B | 12.27 | 4.45% | 1.96% | 4.38% | ||
73 Outperform | ¥11.05B | 8.03 | 1.46% | 0.43% | 2.70% | ||
56 Neutral | ¥12.49B | ― | 2.34% | 1.28% | -449.59% | ||
53 Neutral | C$4.45B | 4.20 | -20.57% | 3.55% | 8.21% | 2.02% | |
41 Neutral | ¥8.06B | ― | ― | -10.64% | -13.47% |